We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

EUROTROL

Eurotrol provides high specification, custom-made quality control (QC) materials for the periodic verification of the... read more Featured Products: More products

Download Mobile App





Eurotrol Highlights CueSee Range of Quality Control Materials for Critical Care, Laboratories and POC Sites

By LabMedica International staff writers
Posted on 28 Sep 2021

Eurotrol, Inc. More...

(Elizabethtown, KY, USA) highlighted its CueSee range of quality control materials for critical care, laboratories and point-of-care sites at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo which took place at the Georgia World Congress Center in Atlanta, September 26-30.

Eurotrol provides quality control materials with specialized formulations for critical care, laboratories and point-of-care sites in hospitals, clinics, proficiency testing providers, standardization bodies and instrument manufacturers (OEM). The company’s menu includes daily QC, calibration verification materials and standards.

At AACC 2021, Eurotrol demonstrated CueSee Ringe, an innovative, patented packaging concept that has modernized the in vitro diagnostics market. A special glass ampoule is sealed inside the CueSee Ringe device. This ampoule breaks with a simple turning motion without the risk of cutting fingers on glass particles or coming into contact with the liquid. After this activation step, the CueSee Ringe functions identically to a standard syringe. The liquid inside the ampoule is not deteriorated by environmental contamination, which reduces pre-analytical errors. This concept is ideal for solutions typically stored in ampoules for quality control, calibration verification, proficiency testing, competency assessment, method validations, and lot comparisons.

Eurotrol also demonstrated its CueSee VeriSTAT that offers complete quality control, cal/ver & reportable range validation for i-STAT test systems. Each liquid covers blood gasses, electrolytes & hematocrit over optimized ranges. Packaged in the new CueSee Ringe, the liquids will have extended open stability of more than five minutes and revolutionary safe opening and simple dosing. Also on display was CueSee Coag in CueSee Mix with its innovative packaging that separates the lyophilized material from the liquid until activation by a simple twist, resulting in a reliable POC Coag QC. CueSee Mix is an innovative dual-chambered device which separates fractions of QC material. CueSee Mix has many applications due to ease of use, no need for pipetting & reduction of matrix interactions – all in a single container. It is ideal for creating liquid matrixes that mimic human specimens & is suitable for QC, proficiency & competency testing, cal/ver & method validation. The CueSee Mix design led to the development of CueSee Coag a unique POC QC. The lyophilized material is kept separate from the liquid until activation by an easy twisting motion. After equilibration, the QC material is safely tested by use of the integrated dropper. CueSee Coag will be available in clinically significant ranges to ensure accurate patient results.

In addition, Eurotrol presented CueSee CO-OX in ACU-Drop II at the event. CueSee CO-OX is a QC for CO-oximeters with real hemoglobin derivatives. Its ACU-Drop II packaging provides long shelf life & ability to provide relevant ranges of all Hgb forms. The two chambered device separates the Hgb fractions until mixed by simply pushing a button. Sampling is easy with the integrated dropper or by attaching a syringe.

Related Links:
Eurotrol, Inc. 


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Blood Gas and Chemistry Analysis System
Edan i500
New
Slide Scanner
VENTANA DP 600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








ADLM

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.